Kintara Therapeutics Inc - ESG Rating & Company Profile powered by AI
This Sustainability assessment for Kintara Therapeutics Inc indicates the company's reporting of the UN SDGs. The page contains a free Sustainability analysis for Kintara Therapeutics Inc. If you are employed by Kintara Therapeutics Inc and you wish to licence your Sustainability rating, please get in touch.
Kintara Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.9; made up of an environmental score of 3.2, social score of 6.4 and governance score of 8.0.
5.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 498 | Redx Pharma PLC | 6.0 | High |
| 498 | Vimta Labs Ltd | 6.0 | High |
| 521 | Kintara Therapeutics Inc | 5.9 | High |
| 521 | Cellink AB | 5.9 | High |
| 521 | Celon Pharma SA | 5.9 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Kintara Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Kintara Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Kintara Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Kintara Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Kintara Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Kintara Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Kintara Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Kintara Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Kintara Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Kintara Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Kintara Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Kintara Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Kintara Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Kintara Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Kintara Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Kintara Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Kintara Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Kintara Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients. Kintara Therapeutics, Inc. has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.